<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Genet</journal-id>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30555518</article-id>
<article-id pub-id-type="pmc">6284054</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2018.00594</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Genetic Diagnostic Evaluation of Trio-Based Whole Exome Sequencing Among Children With Diagnosed or Suspected Autism Spectrum Disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Du</surname>
<given-names>Xiujuan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/582726/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gao</surname>
<given-names>Xueren</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/603587/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Xin</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shen</surname>
<given-names>Lixiao</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Kai</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fan</surname>
<given-names>Yanjie</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sun</surname>
<given-names>Yu</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luo</surname>
<given-names>Xiaomei</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Huili</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Lili</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Yu</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gong</surname>
<given-names>Zhuwen</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Jianguo</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Yongguo</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/604847/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Fei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/549994/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Developmental and Behavioral Pediatric Department – Child Primary Care Department, Brain and Behavioral Research Unit of Shanghai Institute for Pediatric Research and MOE Shanghai Key Laboratory for Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Pediatric Endocrinology and Genetics, Shanghai Institute for Pediatric Research, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Developmental and Behavioral Pediatric Department – Child Primary Care Department, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Wenbo Zhang, The University of Texas Medical Branch at Galveston, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Jing Dong, Baylor College of Medicine, United States; Srinivas Ayyadevara, Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, United States</p>
</fn>
<corresp id="c001">*Correspondence: Yongguo Yu, <email>yuyongguo@shsmu.edu.cn</email> Fei Li, <email>feili@shsmu.edu.cn</email></corresp>
<fn fn-type="other" id="fn002">
<p><sup>†</sup>These authors have contributed equally to this work</p>
</fn>
<fn fn-type="other" id="fn003">
<p>This article was submitted to Genetics of Aging, a section of the journal Frontiers in Genetics</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>30</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>9</volume>
<elocation-id>594</elocation-id>
<history>
<date date-type="received">
<day>01</day>
<month>7</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>11</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Du, Gao, Liu, Shen, Wang, Fan, Sun, Luo, Liu, Wang, Wang, Gong, Wang, Yu and Li.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Du, Gao, Liu, Shen, Wang, Fan, Sun, Luo, Liu, Wang, Wang, Gong, Wang, Yu and Li</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Autism spectrum disorder (ASD) is a group of clinically and genetically heterogeneous neurodevelopmental disorders. Recent tremendous advances in the whole exome sequencing (WES) enable rapid identification of variants associated with ASD including single nucleotide variations (SNVs) and indels. To further explore genetic etiology of ASD in Chinese children with negative findings of copy number variants (CNVs), we applied WES in 80 simplex families with a single affected offspring with ASD or suspected ASD, and validated variations predicted to be damaging by Sanger sequencing. The results showed that an overall diagnostic yield of 8.8% (9.2% in the group of ASD and 6.7% in the group of suspected ASD) was observed in our cohort. Among patients with diagnosed ASD, developmental delay or intellectual disability (DD/ID) was the most common comorbidity with a diagnostic yield of 13.3%, followed by seizures (50.0%) and craniofacial anomalies (40.0%). All of identified <italic>de novo</italic> SNVs and indels among patients with ASD were loss of function (LOF) variations and were slightly more frequent among female (male vs. female: 7.3% vs. 8.5%). A total of seven presumed causative genes (<italic>CHD8, AFF2, ADNP, POGZ, SHANK3, IL1RAPL1</italic>, and <italic>PTEN</italic>) were identified in this study. In conclusion, WES is an efficient diagnostic tool for diagnosed ASD especially those with negative findings of CNVs and other neurological disorders in clinical practice, enabling early identification of disease related genes and contributing to precision and personalized medicine.</p>
</abstract>
<kwd-group>
<kwd>autism spectrum disorder</kwd>
<kwd>whole exome sequencing</kwd>
<kwd>diagnostic yield</kwd>
<kwd>comorbidity</kwd>
<kwd>genetic etiology</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="2"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="52"></ref-count>
<page-count count="8"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>Autism spectrum disorder (ASD) is a group of highly heterogeneous neurodevelopmental disorders affecting 1 in 59 children aged 8 years, with boys four times more likely to be affected than girls (<xref ref-type="bibr" rid="B3">Baio et al., 2018</xref>). It’s characterized by impaired reciprocal social interaction and communication, as well as restricted repetitive interests and behaviors (<xref ref-type="bibr" rid="B49">The Lancet, 2010</xref>). The symptoms could develop gradually from early childhood, affecting daily functioning and persisting throughout one’s life (<xref ref-type="bibr" rid="B45">Stefanatos, 2008</xref>). Given the variety of phenotypes and severity, it’s believed that genetic factors play a key role in the pathogenesis of ASD, in combination with developmental environmental factors (<xref ref-type="bibr" rid="B19">Hofvander et al., 2009</xref>; <xref ref-type="bibr" rid="B29">Mattila et al., 2010</xref>; <xref ref-type="bibr" rid="B2">Anagnostou et al., 2014</xref>).</p>
<p>The clinical and genetic heterogeneity of ASD has proved to be challenging to the diagnostic workup of affected patients. Routine testing for Fragile X syndrome, karyotyping and chromosomal microarray (CMA) have been established as the first-tier tests for patients with ASD for several years, accounting only for about 1–2%, 5%, and 5–10% cases, respectively (<xref ref-type="bibr" rid="B43">Shen et al., 2010</xref>; <xref ref-type="bibr" rid="B6">Betancur, 2011</xref>; <xref ref-type="bibr" rid="B44">State and Levitt, 2011</xref>; <xref ref-type="bibr" rid="B11">Devlin and Scherer, 2012</xref>). Certain loci were identified to confer risk for ASD, and 16p11.2, 15q11-q13, and 22q11.2 were the most frequent (<xref ref-type="bibr" rid="B28">Marshall et al., 2008</xref>; <xref ref-type="bibr" rid="B50">Weiss et al., 2008</xref>; <xref ref-type="bibr" rid="B13">Fernandez et al., 2010</xref>; <xref ref-type="bibr" rid="B20">Hogart et al., 2010</xref>; <xref ref-type="bibr" rid="B18">Hiroi et al., 2013</xref>). In addition, several genes identified by copy number variants (CNVs) screening and target sequencing for candidate genes were related to ASD susceptibility, such as <italic>PTCHD1, NRXN1, NLGN3, SHANK3, SHANK1</italic> and so on (<xref ref-type="bibr" rid="B24">Jamain et al., 2003</xref>; <xref ref-type="bibr" rid="B31">Moessner et al., 2007</xref>; <xref ref-type="bibr" rid="B25">Kim et al., 2008</xref>; <xref ref-type="bibr" rid="B34">Noor et al., 2010</xref>; <xref ref-type="bibr" rid="B42">Sato et al., 2012</xref>; <xref ref-type="bibr" rid="B9">Dabell et al., 2013</xref>). Recent rapidly improved accuracy and decreased cost of whole-exome sequencing (WES) enabled the application among proband-parent trios of ASD in clinical practice, opening the way to the discovery of single nucleotide variations (SNVs) and indels (<xref ref-type="bibr" rid="B41">Sanders et al., 2012</xref>; <xref ref-type="bibr" rid="B36">O’Roak et al., 2014</xref>). By using WES, ∼ 20.0% patients with sporadic ASD could be identified and this rate even reached to ∼90% because of the highly inbred nature of the Saudi population, making it useful in complementing CMA designed to detect CNVs, and better characterizing the genetic architecture for ASD in simplex families (<xref ref-type="bibr" rid="B35">O’Roak et al., 2011</xref>; <xref ref-type="bibr" rid="B52">Yu et al., 2013</xref>; <xref ref-type="bibr" rid="B47">Tammimies et al., 2015</xref>; <xref ref-type="bibr" rid="B1">Al-Mubarak et al., 2017</xref>). However, thus far, there remains a gap in our knowledge of the diagnostic yield of trio-WES among Chinese children with autistic features when CMA is unable to detect risk-related variations, and its impacts on clinical practice.</p>
<p>It is estimated that more than 70% of individuals with ASD have comorbidities including developmental and psychiatric disorders (<xref ref-type="bibr" rid="B19">Hofvander et al., 2009</xref>; <xref ref-type="bibr" rid="B26">Kohane et al., 2012</xref>). Based on the suspicion that genetic mechanism of children suffered an abnormality of morphogenesis differed from those who did not, <xref ref-type="bibr" rid="B30">Miles et al. (2005)</xref> collected data of dysmorphisms among children with ASD. The patients were further divided into two subsets of patients with documented dysmorphology (complex group) and without evident disrupted morphogenesis (essential group). The findings demonstrated that an abnormal karyotype (2.3%) or a clinically recognized syndrome (1.9%) were identified and restricted to complex group. Triggered by this incentive, we classified patients into different subgroups according to clinical manifestations, to explore the utility of WES and better characterize the underlining genetic differences.</p>
<p>In an attempt to expand the genetic spectrum of ASD by identifying novel SNV and indels, and evaluate how well WES could make up the deficiency of CMA in China, trio-based WES was further implemented among 80 children diagnosed as ASD and suspected of having ASD with negative findings of CMA.</p>
</sec>
<sec id="s1" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec>
<title>Patients</title>
<p>Data were collected from children visiting the outpatient clinic of Department of Developmental Behavioral Pediatric and Children Healthcare at Xinhua Hospital, Shanghai, China during March to December 2017. Without detection of CNVs related to ASD, a total of 80 unrelated children (aged 4 months to 13 years) with autistic features were enrolled to further complete trio-based whole exome sequencing (WES). All probands did not have neurological disorders (such as cerebral palsy and schizophrenia) or have the known chromosome/genetic disorders (such as trisomy 21 syndrome, trisomy 18 syndrome, trisomy 13 syndrome, Rett syndrome, Fragile X syndrome). Chromosome microarray analysis were applied by using Cyto Scan HD array (Affymetrix, Santa Clara, CA, United States).</p>
<p>Of these children, 65 (55 males and 10 females) were diagnosed as ASD using standard evaluation including Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DMS-5), the Autism Diagnostic Observation Schedule (ADOS), Childhood Autism Rating Scale (CARS) and the intellectual assessment by clinicians. By intellectual assessment, the patients with developmental quotient (DQ) &lt; 75 assessed using Gesell development scales, and intelligence quotient (IQ) &lt; 70 assessed using WISC-R or WPPSI (Wechsler Intelligence Scale for children) were diagnosed as developmental delay or intellectual disability (DD/ID). With related evaluation not available, the rest of children exhibiting clinician-reported autistic features were suspected of having ASD. The study was approved by the ethical committee at Xinhua hospital and conducted in accordance with the relevant guidelines and regulations. Written informed consent in accordance with the Declaration of Helsinki was obtained from the patients and parents. And we have been adhered to standard biosecurity and institutional safety procedures in this study.</p>
</sec>
<sec>
<title>DNA Samples, WES, and Bioinformatics Analysis</title>
<p>Peripheral blood leukocytes from 80 children and parents were obtained. Genomic DNA (gDNA) was extracted using Lab-Aid Nucleic Acid (DNA) Isolation Kit (Zeesan, China), according to the manufacturer’s instructions. The preparation of library of WES was completed using xGen Exome research panel v1.0 (Integrated DNA Technologies, Coralville, IA, United States). Sequencing was performed using paired 150-end, 150-cycle chemistry on the Illumina HiSeq 4000 (Illumina, San Diego, CA, United States), according to the manufacturer’s instructions. Burrows-Wheeler Aligner (BWA, version 0.7.10) was used for FASTQ files to mapping reads to the human reference genome (GRCh37/hg19). Base calling, QC analysis and coverage analysis was performed with Picard tools-1.124 and GATK software. Variants were then annotated using SnpEff version 4.2. Stepwise variant filtering are as follows: variants that demonstrated &gt;1% frequency in the population variant databases including 1000 Genomes Project, Exome Variant Server (EVS) and Exome Aggregation Consortium (ExAC) or &gt;5% frequency in our in-house database (based on 150 exome datasets), and intergenic and 3′/5′ untranslated region variants, none splice-related intronic and synonymous variants were filtered, with those located at canonical splice sites excluded.</p>
<p>Combined with clinical manifestation and modes of inheritance, Sanger sequencing and DNA-based paternity testing were performed to validate the putative pathogenic mutation for all family members. Sequencing products were analyzed using an ABI 3730xl DNA Analyzer (Applied Biosystems, Foster City, CA, United States). For DNA-based paternity testing, the Identifiler<sup>TM</sup> system and the ABI 3730xL DNA Analyzer (Applied Biosystems) were used to perform multiplex polymerase chain reaction (PCR) amplification and genotyping of PCR products with capillary electrophoresis, respectively. Primer sequences used for validation have been showed in Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S1</xref>.</p>
<p>MutationTaster<sup><xref ref-type="fn" rid="fn01">1</xref></sup>, SIFT<sup><xref ref-type="fn" rid="fn02">2</xref></sup>, and PolyPhen-2<sup><xref ref-type="fn" rid="fn03">3</xref></sup> were used to assess the effect of variants on protein function. Validated variants were classified as pathogenic, likely pathogenic, variants of uncertain clinical significance (VUS), likely benign and benign, based on standards and guidelines of the American College of Medical Genetics and Genomics (ACMG). Potential causative genetic variants have been deposited in database of LOVD<sup><xref ref-type="fn" rid="fn04">4</xref></sup>, with associated accession numbers ranging from #0000379121 to #0000379127.</p>
</sec>
</sec>
<sec>
<title>Results</title>
<sec>
<title>Clinical Characteristics of Patients</title>
<p>The clinical characteristics of children with diagnosed ASD and suspected ASD were summarized in Table <xref ref-type="table" rid="T1">1</xref>. Among the patients with ASD, there were 23 children younger than 3 years, 30 children from 3 to 6 year of age (diagnostic rate = 16.7%) and 12 children older than 6 years (diagnostic rate = 8.3%) and the male/female ratio was 53/12. 41 out of 60 patients diagnosed as ASD with available behavioral assessments had CARS scores ≧37 (diagnostic rate = 7.3%), suggesting a severe autistic behavior.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Clinical characteristics of children with ASD and suspected ASD in the current study.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Characteristic</th>
<th align="center" colspan="2" rowspan="1" valign="top">Children with ASD<hr/></th>
<th align="center" colspan="2" rowspan="1" valign="top">Children with suspected ASD<hr/></th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top"></th>
<th align="center" colspan="1" rowspan="1" valign="top">No.</th>
<th align="center" colspan="1" rowspan="1" valign="top">Diagnostic rate</th>
<th align="center" colspan="1" rowspan="1" valign="top">No.</th>
<th align="center" colspan="1" rowspan="1" valign="top">Diagnostic rate</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Age at testing, y</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">&lt;3</td>
<td align="center" colspan="1" rowspan="1" valign="top">23</td>
<td align="center" colspan="1" rowspan="1" valign="top">0/23 (0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">7</td>
<td align="center" colspan="1" rowspan="1" valign="top">1/7 (14.3%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3–6</td>
<td align="center" colspan="1" rowspan="1" valign="top">30</td>
<td align="center" colspan="1" rowspan="1" valign="top">5/30 (16.7%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">5</td>
<td align="center" colspan="1" rowspan="1" valign="top">0/5 (0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">≧6</td>
<td align="center" colspan="1" rowspan="1" valign="top">12</td>
<td align="center" colspan="1" rowspan="1" valign="top">1/12 (8.3%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">3</td>
<td align="center" colspan="1" rowspan="1" valign="top">0/3 (0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sex</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Male</td>
<td align="center" colspan="1" rowspan="1" valign="top">53</td>
<td align="center" colspan="1" rowspan="1" valign="top">5/53 (9.4%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">10</td>
<td align="center" colspan="1" rowspan="1" valign="top">1/10 (10.0%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Female</td>
<td align="center" colspan="1" rowspan="1" valign="top">12</td>
<td align="center" colspan="1" rowspan="1" valign="top">1/12 (8.3%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">5</td>
<td align="center" colspan="1" rowspan="1" valign="top">0/5 (0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CARS</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">30.0–36.5</td>
<td align="center" colspan="1" rowspan="1" valign="top">19</td>
<td align="center" colspan="1" rowspan="1" valign="top">3/19 (15.8 %)</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">37.0–60.0</td>
<td align="center" colspan="1" rowspan="1" valign="top">41</td>
<td align="center" colspan="1" rowspan="1" valign="top">3/41 (7.3%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Principal phenotypic feature</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">DD/ID</td>
<td align="center" colspan="1" rowspan="1" valign="top">45</td>
<td align="center" colspan="1" rowspan="1" valign="top">6/45 (13.3%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">7</td>
<td align="center" colspan="1" rowspan="1" valign="top">1/7 (14.3%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Gastrointestinal disorders</td>
<td align="center" colspan="1" rowspan="1" valign="top">25</td>
<td align="center" colspan="1" rowspan="1" valign="top">3/25 (12.0%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">0/1 (0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ADHD</td>
<td align="center" colspan="1" rowspan="1" valign="top">8</td>
<td align="center" colspan="1" rowspan="1" valign="top">0/8 (0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">0/1 (0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sleep disturbances</td>
<td align="center" colspan="1" rowspan="1" valign="top">6</td>
<td align="center" colspan="1" rowspan="1" valign="top">0/6 (0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Craniofacial anomalies</td>
<td align="center" colspan="1" rowspan="1" valign="top">5</td>
<td align="center" colspan="1" rowspan="1" valign="top">2/5 (40.0%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">4</td>
<td align="center" colspan="1" rowspan="1" valign="top">0/4 (0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Short stature</td>
<td align="center" colspan="1" rowspan="1" valign="top">5</td>
<td align="center" colspan="1" rowspan="1" valign="top">2/5 (40.0%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">0/1 (0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Seizures</td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
<td align="center" colspan="1" rowspan="1" valign="top">1/2 (50.0%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
<td align="center" colspan="1" rowspan="1" valign="top">0/2 (0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Congenital heart disease</td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
<td align="center" colspan="1" rowspan="1" valign="top">0/2 (0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">0/1 (0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Obesity</td>
<td align="center" colspan="1" rowspan="1" valign="top">3</td>
<td align="center" colspan="1" rowspan="1" valign="top">0/3 (0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Microcephaly/Macrocephaly</td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
<td align="center" colspan="1" rowspan="1" valign="top">0/2 (0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
<td align="center" colspan="1" rowspan="1" valign="top">1/2 (50.0%)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib><italic>ASD, autism spectrum disorder; CARS, Childhood Autism Rating Scale; DD/ID, developmental delay or intellectual disability; ADHD, attention deficit hyperactivity disorder; –, absent</italic>.</attrib>
</table-wrap-foot>
</table-wrap>
<p>In terms of other clinical phenotypes, DD/ID was the most common comorbidity in both groups of patients with ASD and suspected ASD. A variety of neurological and non-neurological deficits were exhibit among patients with ASD, including DD/ID (<italic>n</italic> = 45, diagnostic rate = 13.3%), seizures (<italic>n</italic> = 2, diagnostic rate = 50.0%), craniofacial anomalies (<italic>n</italic> = 5, diagnostic rate = 40.0%), etc. (Table <xref ref-type="table" rid="T1">1</xref>).</p>
</sec>
<sec>
<title>Molecular Genetic Findings of WES</title>
<p>WES was performed among 80 trios with diagnosed or suspected ASD. Quality control of sequencing showed that 97.8% of the reads were mapped to the reference genome, and 97.7% of the targeted regions were covered by ≧10X reads with enough average depth (138X) (Supplementary Table <xref ref-type="supplementary-material" rid="SM2">S2</xref>). And details of QC (the depth, the coverage and the target regions covered by ≧10X reads) were shown in Figure <xref ref-type="fig" rid="F1">1</xref>. Potential causative variants were subsequently confirmed by Sanger sequencing.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Quality control (QC) of whole exome sequencing. <bold>(A)</bold> QC of the depth; <bold>(B)</bold> QC of the coverage and the targeted regions covered by ≧10X reads.</p>
</caption>
<graphic xlink:href="fgene-09-00594-g001"></graphic>
</fig>
<p>A conclusive genetic diagnosis were obtained in seven of 80 children identified by WES, corresponding to an overall diagnostic yield of 8.8% (9.2% in the group of ASD and 6.7% in the group of suspected ASD). We detected and validated a total of seven variants and each was identified in a different gene (Table <xref ref-type="table" rid="T2">2</xref>). Based on the distribution of the confirmed variants, frameshift were the most common (3/7), followed by the missense (2/7), stop gained (1/7) and start lost variants (1/7). Among the causative variants, the presumed mode of inheritance was autosomal dominant in 71.4% (71.4% <italic>de novo</italic>), and X-linked in 28.6% (14.3% <italic>de novo</italic> and 14.3% inherited).</p>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>Clinical and molecular findings in children with positive results of WES.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">ID</th>
<th align="center" colspan="1" rowspan="1" valign="top">Sex</th>
<th align="left" colspan="1" rowspan="1" valign="top">Age at testing, y</th>
<th align="left" colspan="1" rowspan="1" valign="top">Clinical presentation</th>
<th align="left" colspan="1" rowspan="1" valign="top">Molecular diagnosis</th>
<th align="left" colspan="1" rowspan="1" valign="top">Gene</th>
<th align="left" colspan="1" rowspan="1" valign="top">Sequence variant</th>
<th align="left" colspan="1" rowspan="1" valign="top">Zygosity</th>
<th align="left" colspan="1" rowspan="1" valign="top">Interpretation</th>
<th align="center" colspan="1" rowspan="1" valign="top">ACMG classification</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">
<bold>Diagnosed ASD</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ASD-685</td>
<td align="center" colspan="1" rowspan="1" valign="top">M</td>
<td align="left" colspan="1" rowspan="1" valign="top">4 years 7 months</td>
<td align="left" colspan="1" rowspan="1" valign="top">DD/ID</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phelan-McDermid syndrome (OMIM:606232)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SHANK3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NM_033517.1: c.3630dupG; p.L1210fs</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>De novo</italic> het</td>
<td align="left" colspan="1" rowspan="1" valign="top">Frameshift</td>
<td align="center" colspan="1" rowspan="1" valign="top">P</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ASD-667</td>
<td align="center" colspan="1" rowspan="1" valign="top">M</td>
<td align="left" colspan="1" rowspan="1" valign="top">4 years 8 months</td>
<td align="left" colspan="1" rowspan="1" valign="top">DD/ID, gastrointestinal disorders</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mental retardation X-linked FRAXE type (OMIM:309548)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>AFF2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NM_002025.3: c.2509C&gt;T; p.Arg837Cys</td>
<td align="left" colspan="1" rowspan="1" valign="top">Maternal hemi</td>
<td align="left" colspan="1" rowspan="1" valign="top">Missense</td>
<td align="center" colspan="1" rowspan="1" valign="top">P</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ASD-706</td>
<td align="center" colspan="1" rowspan="1" valign="top">M</td>
<td align="left" colspan="1" rowspan="1" valign="top">4 years 11 months</td>
<td align="left" colspan="1" rowspan="1" valign="top">DD/ID, seizures, craniofacial anomalies</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mental retardation X-linked 21/34 (OMIM:300143)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>IL1RAPL1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NM_014271.3: c.1489C&gt;T; p.Arg497<sup>∗</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>De novo</italic> hemi</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stop gained</td>
<td align="center" colspan="1" rowspan="1" valign="top">P</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ASD-817</td>
<td align="center" colspan="1" rowspan="1" valign="top">M</td>
<td align="left" colspan="1" rowspan="1" valign="top">7 years 11 months</td>
<td align="left" colspan="1" rowspan="1" valign="top">DD/ID, short stature</td>
<td align="left" colspan="1" rowspan="1" valign="top">White-Sutton syndrome (OMIM:616364)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>POGZ</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NM_015100.3: c.1178_1181 delinsCC; p.H393Pfs<sup>∗</sup>10</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>De novo</italic> het</td>
<td align="left" colspan="1" rowspan="1" valign="top">Frameshift</td>
<td align="center" colspan="1" rowspan="1" valign="top">P</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ASD-867</td>
<td align="center" colspan="1" rowspan="1" valign="top">F</td>
<td align="left" colspan="1" rowspan="1" valign="top">3 years 2 months</td>
<td align="left" colspan="1" rowspan="1" valign="top">DD/ID</td>
<td align="left" colspan="1" rowspan="1" valign="top">{Autism, susceptibility to, 18} (OMIM:615032)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CHD8</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NM_001170629.1:c.4611dupA; p.Val1538fs</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>De novo</italic> het</td>
<td align="left" colspan="1" rowspan="1" valign="top">Frameshift</td>
<td align="center" colspan="1" rowspan="1" valign="top">P</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ASD-821</td>
<td align="center" colspan="1" rowspan="1" valign="top">M</td>
<td align="left" colspan="1" rowspan="1" valign="top">4 years 11 months</td>
<td align="left" colspan="1" rowspan="1" valign="top">DD/ID, craniofacial anomalies, short stature micropenis, anal stenosis,</td>
<td align="left" colspan="1" rowspan="1" valign="top">Helsmoortel-van der Aa syndrome (OMIM:615873)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ADNP</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NM_015339.3: c.2T&gt;C; p. Met1Thr</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>De novo</italic> het</td>
<td align="left" colspan="1" rowspan="1" valign="top">Start lost</td>
<td align="center" colspan="1" rowspan="1" valign="top">P</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">
<bold>Suspected ASD</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">M</td>
<td align="left" colspan="1" rowspan="1" valign="top">2 years</td>
<td align="left" colspan="1" rowspan="1" valign="top">DD/ID, Macrocephaly</td>
<td align="left" colspan="1" rowspan="1" valign="top">Macrocephaly/autism syndrome (OMIM:605309)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>PTEN</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NM_000314.6: c.737C&gt;T; p.Pro246Leu</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>De novo</italic> het</td>
<td align="left" colspan="1" rowspan="1" valign="top">Missense</td>
<td align="center" colspan="1" rowspan="1" valign="top">P</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib><italic>ASD, autism spectrum disorder; WES, whole exome sequencing; DD/ID, developmental delay or intellectual disability; P, pathogenic; -, absent</italic>.</attrib>
</table-wrap-foot>
</table-wrap>
<p><italic>De novo</italic> mutations accounted for 85.7% (six of seven) of the overall molecular diagnoses. Among patients with diagnosed ASD, all of identified <italic>de novo</italic> SNVs and indels were loss of function (LOF) variations and were slightly more frequent among female (male vs. female: 7.3% vs. 8.5%). In addition, all of patients with diagnosed ASD revealed to carry <italic>de novo</italic> LOF variations were co-occurring with DD/ID. A <italic>de novo</italic> missense variation was identified in one patient with suspected ASD. In total, seven genes (<italic>CHD8, AFF2, ADNP, POGZ, SHANK3, IL1RAPL1</italic>, and <italic>PTEN</italic>) with presumed pathogenic variations were identified in this study.</p>
</sec>
<sec>
<title>Impact of WES on Clinical Management</title>
<p>The discovery of WES makes both early clinical detection and genetic counseling possible in various ways among four of seven probands with a conclusive molecular diagnosis. In addition to the following up for ASD based on the risk genes, these patients received further workup of systemic involvement in this cohort. For example, developmental and behavioral evaluation were conducted in the patients with variants of <italic>AFF2</italic> and <italic>IL1RAPL1</italic>, respectively; seizures, short stature, abnormalities of skeleton system, eye, ear, brain and gastrointestinal tract screening, and developmental and behavioral evaluation were implemented in the patient with a <italic>de novo</italic> SNV of <italic>POGZ</italic>; hormone deficiency, short stature, obesity, hypotonia, seizures and feeding problems screening were evaluated in the patient with a <italic>de novo</italic> SNV of <italic>ADNP</italic>. And correspondingly, medication was changed. Growth hormone was applied in patients with <italic>ADNP</italic> and <italic>POGZ</italic> based on the diagnosis of short stature. Brain protein hydrolysate was discontinued in patients with seizures. Two couples with future pregnancy were informed the importance of prenatal testing and preimplantation genetic diagnosis.</p>
</sec>
</sec>
<sec>
<title>Discussion</title>
<p>With the advent of decreasing cost combined with superior efficiency of WES, studies focusing on the contribution of <italic>de novo</italic> and/or inherited mutations become affordable as well as avoid the potential ‘diagnostic odyssey’ (<xref ref-type="bibr" rid="B4">Bamshad et al., 2011</xref>; <xref ref-type="bibr" rid="B35">O’Roak et al., 2011</xref>; <xref ref-type="bibr" rid="B48">Tan et al., 2017</xref>). In this study, with negative findings of ASD-related CNVs by using CMA, we further confirmed utility of trio-WES for diagnosis among children with ASD or suspected ASD in clinical practice. All <italic>de novo</italic> and inherited variants with predicted damaging effect were validated by Sanger sequencing in both patients and parents. Genetic etiology was identified in seven of 80 trios with an overall detection rate of 8.8%. Within the diagnosed ASD group, six of 65 (9.2%) patients received molecular diagnoses, which was similar to the results observed among sporadic ASD (8.4%), as well as those focusing on either <italic>de novo</italic> or inherited variations, ranging from 6.3% to 13.8% (<xref ref-type="bibr" rid="B32">Neale et al., 2012</xref>; <xref ref-type="bibr" rid="B41">Sanders et al., 2012</xref>; <xref ref-type="bibr" rid="B10">De Rubeis et al., 2014</xref>; <xref ref-type="bibr" rid="B12">Dong et al., 2014</xref>; <xref ref-type="bibr" rid="B21">Iossifov et al., 2014</xref>; <xref ref-type="bibr" rid="B47">Tammimies et al., 2015</xref>). An interesting finding emerging from this study implied the importance of completed ASD-related assessments in enabling a higher diagnostic yield among patients with suspected ASD. Our data showed that compared with children with suspected ASD (6.7%), the diagnostic yield was higher among patients with diagnosed ASD (9.2%). Moreover, diagnostic rate seemed high among ASD patients suffering from other neurodevelopmental disorders including DD/ID, suggesting that patients with these comorbidities may benefit more from WES. These findings were supported by the work of Tammimies et al. who recommended WES as a first-tier test for ASD, especially when comorbid with physical and congenital anomalies (<xref ref-type="bibr" rid="B47">Tammimies et al., 2015</xref>). To some extent, the relatively higher yield might result from the patients diagnosed and managed in the outpatient. Those who were diagnosed as ASD especially co-occurring with other neurodevelopmental disorders, are more likely undergone etiological testing including WES, given a high suspicion of genetic etiology.</p>
<p>The past few years have witnessed increasing studies of ASD trios published, highlighting the role of <italic>de novo</italic> variants and improving the identification of candidate risk genes for ASD (<xref ref-type="bibr" rid="B35">O’Roak et al., 2011</xref>; <xref ref-type="bibr" rid="B21">Iossifov et al., 2014</xref>). Given that <italic>de novo</italic> variation is less frequent and potentially more deleterious, we evaluated its diagnostic rates and effects to determine risk genes. Among children with diagnosed ASD, <italic>de novo</italic> variations were observed in 83.3% of the patients. Moreover, <italic>de novo</italic> LOF mutations contribute to 87.5% cases with ASD. Our findings that <italic>de novo</italic> variations of LOF predominant is contrary to previous population-based studies is intriguing (<xref ref-type="bibr" rid="B22">Iossifov et al., 2012</xref>; <xref ref-type="bibr" rid="B37">O’Roak et al., 2012</xref>; <xref ref-type="bibr" rid="B41">Sanders et al., 2012</xref>). One possible explanation is that ASD patients with other neurodevelopment disorders are prior to be tested by WES in outpatient, and may limit generalizability to the broader ASD population. Another key finding demonstrated here, was that in spite of a predominant male to female ratio (about 4:1), <italic>de novo</italic> LOF mutations were slightly more enriched in females with ASD. And this finding was consistent with the previous results (<xref ref-type="bibr" rid="B27">Levy et al., 2011</xref>; <xref ref-type="bibr" rid="B22">Iossifov et al., 2012</xref>). Genetic studies suggest that the strong male bias in liability might be attributed to a female protective effect, in which a higher load of mutations were tolerated by female (<xref ref-type="bibr" rid="B15">Gilman et al., 2011</xref>; <xref ref-type="bibr" rid="B27">Levy et al., 2011</xref>). An increasing body of evidence indicates that affected female with ASD are more susceptible to <italic>de novo</italic> SNVs and indels of LOF (<xref ref-type="bibr" rid="B32">Neale et al., 2012</xref>; <xref ref-type="bibr" rid="B41">Sanders et al., 2012</xref>; <xref ref-type="bibr" rid="B10">De Rubeis et al., 2014</xref>; <xref ref-type="bibr" rid="B12">Dong et al., 2014</xref>; <xref ref-type="bibr" rid="B21">Iossifov et al., 2014</xref>; <xref ref-type="bibr" rid="B23">Jacquemont et al., 2014</xref>). In addition to variations mentioned before, large CNVs encompassing more genes and probably more damaging, are especially abundant in affected females (<xref ref-type="bibr" rid="B27">Levy et al., 2011</xref>; <xref ref-type="bibr" rid="B40">Sanders et al., 2011</xref>; <xref ref-type="bibr" rid="B23">Jacquemont et al., 2014</xref>). These findings suggest to us that other underlying factors that have not yet been identified may contributes much more in males than in females.</p>
<p>All of genes with presumed causative mutations identified here were previously reported in ASD (<xref ref-type="bibr" rid="B17">Herman et al., 2007</xref>; <xref ref-type="bibr" rid="B38">Piton et al., 2008</xref>; <xref ref-type="bibr" rid="B33">Nishiyama et al., 2009</xref>; <xref ref-type="bibr" rid="B5">Bernier et al., 2014</xref>; <xref ref-type="bibr" rid="B8">Colak et al., 2014</xref>; <xref ref-type="bibr" rid="B16">Helsmoortel et al., 2014</xref>; <xref ref-type="bibr" rid="B46">Stessman et al., 2016</xref>; <xref ref-type="bibr" rid="B51">Yi et al., 2016</xref>). Six genes (<italic>CHD8, AFF2, ADNP, POGZ, SHANK3</italic>, and <italic>IL1RAPL1</italic>) were identified among patients with diagnosed ASD with DD/ID (<xref ref-type="bibr" rid="B38">Piton et al., 2008</xref>; <xref ref-type="bibr" rid="B33">Nishiyama et al., 2009</xref>; <xref ref-type="bibr" rid="B5">Bernier et al., 2014</xref>; <xref ref-type="bibr" rid="B8">Colak et al., 2014</xref>; <xref ref-type="bibr" rid="B16">Helsmoortel et al., 2014</xref>; <xref ref-type="bibr" rid="B46">Stessman et al., 2016</xref>; <xref ref-type="bibr" rid="B51">Yi et al., 2016</xref>). In spite of <italic>de novo</italic> LOF variations detected in <italic>SHANK3</italic> and <italic>CHD8</italic>, patient ASD-685 and ASD-867 presented ASD and DD/ID without other disorders at the age of testing. <italic>SHANK3</italic> was a gene encoding a scaffolding protein that is enriched in postsynaptic densities of excitatory synapses (<xref ref-type="bibr" rid="B51">Yi et al., 2016</xref>). And <italic>CHD8</italic>, allelic variants of which are associated with ASD, encoding the protein chromodomain helicase DNA binding protein 8 (<xref ref-type="bibr" rid="B33">Nishiyama et al., 2009</xref>), which is a chromatin regulator enzyme that is essential during fetal development (<xref ref-type="bibr" rid="B39">Ronan et al., 2013</xref>). At present, the mechanism of the higher incidence in males remains inconclusive, and hormones, sex-specific brain differences or variation on the sex chromosomes were speculated to play a role in. We identified two variants (one missense and one <italic>de novo</italic> LOF) in two X-chromosome genes (<italic>AFF2</italic> and <italic>IL1RAPL1</italic>). <italic>AFF2</italic> whose function is to encode a putative transcriptional activator that is a member of the AF4∖FMR2 gene family, was previously associated with ASD and mental retardation, X-linked, FRAXE type (<xref ref-type="bibr" rid="B8">Colak et al., 2014</xref>). And in patient ASD-667 with a missense mutation in <italic>AFF2</italic> displayed gastrointestinal disorders in addition to DD/ID. Patient ASD-706 with a <italic>de novo</italic> LOF variation in <italic>IL1RAPL1</italic> showed ASD co-occurring with DD/ID, seizures and craniofacial anomalies. This gene is highly expressed in post-natal brain structures, which functions in the hippocampal memory system, thus suggesting a key role in the physiological processes underlying memory and learning abilities (<xref ref-type="bibr" rid="B14">Gambino et al., 2007</xref>). A <italic>de novo</italic> LOF variation in <italic>POGZ</italic> was identified in patient ASD-817 with DD/ID and short stature. Interestingly, previous reports showed patients with variation in <italic>ADNP</italic> often displayed Helsmoortel-van der Aa syndrome (<xref ref-type="bibr" rid="B16">Helsmoortel et al., 2014</xref>). However, without obesity and short stature at age of diagnosis, patients ASD-821 harboring a <italic>de novo</italic> LOF mutation (start lost) in <italic>ADNP</italic> presented novel phenotype of micropenis and anal stenosis. After genetic counseling, this patient were screened by biochemical tests related to hormone deficiency, short stature and suggested to be followed up in Department of Pediatric Endocrinology/Genetics. There remains one gene (<italic>PTEN</italic>) with a <italic>de novo</italic> missense variation was detected in a child with suspected ASD. This child presented typically macrocephaly and DD/ID. <italic>PTEN</italic> identified as a tumor suppressor is mutated in a large number of cancers at high frequency (<xref ref-type="bibr" rid="B7">Bonneau and Longy, 2000</xref>). These results implied that a continuum of neurological and non-neurological disorders that present in varied patterns might result from candidate risk genes by interacting with other factors.</p>
<p>To our knowledge, this work represents the first comprehensive analysis in Chinese children with diagnosed and suspected ASD by trio-based WES. Similar to other studies by WES, one of potential limitations is that true causative variants may be omitted as a result of stringent criteria to filter false-positives. Besides, WES has limited ability to detect genomic imbalances and could not evaluate variations located on non-coding sequences. Notwithstanding the small sample size, our study in part contributes to dataset of phenotype and genetic etiology of ASD in Chinese children. Moreover, we confirmed the utility of WES in patients without positive results of CNVs, improving the detection rate in a way. Accordingly, many challenges remain, it’s hopeful for a brighter future of individuals with ASD and their families benefiting from the advantages of WES.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>In conclusion, WES offers the advantage of early screening of the underlying ASD-related genes when related CNVs were not identified by CMA, providing genetic diagnoses across diverse clinical subgroups and contributing to precision and personalized medicine.</p>
</sec>
<sec>
<title>Data Availability Statement</title>
<p>The potential causative variants in this study can be found in the LOVD database (<ext-link ext-link-type="uri" xlink:href="https://databases.lovd.nl/shared/variants?search_owned_by_=%3D%22Fei%20Li%22">https://databases.lovd.nl/shared/variants?search_owned_by_=%3D%22Fei%20Li%22</ext-link>), with associated accession numbers ranging from #0000379121 to #0000379127.</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>FL and YY conceived and designed the study. XG performed the experiments. XD and XG drafted the manuscript. XL and XD collected the samples from ASD families. FL and LS made diagnoses, and interpreted the clinical data. XG, YF, YS, XL, HL, LW, YW, ZG, and JW analyzed the exome sequencing data. XL and KW were responsible for obtaining study ethics and collected clinical data. The authors jointly discussed the experimental results throughout the duration of the study. All authors reviewed and approved the final manuscript.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> The work was financially supported by funding from Shanghai Municipal Commission of Health and Family Planning (Grant Nos. 2017ZZ02026, 2018BR33, 2017EKHWYX-02, GDEK201709, and 201740192), Shanghai Shenkang Hospital Development Center (Grant No. 16CR2025B), Shanghai Municipal Education Commission (Grant No. 20152234), National Natural Science Foundation of China (Grant Nos. 81571031, 81761128035, and 81670812), Shanghai Committee of Science and Technology (Grant Nos. 17XD1403200 and 18DZ2313505), Xinhua Hospital of Shanghai Jiao Tong University School of Medicine (2018YJRC03, Talent introduction-014, Top talent-201603), Jiao Tong University Cross Biomedical Engineering (Grant No. YG2017MS72), Shanghai Shen Kang Hospital Development Center new frontier technology joint project (Grant No. SHDC12017109), Youth Research Project of the Shanghai Municipal Health and Family Planning Commission (Grant No. 20184Y0348).</p>
</fn>
</fn-group>
<ack>
<p>The authors gratefully thank all the patients and their families.</p>
</ack>
<fn-group>
<fn id="fn01">
<label>1</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://www.mutationtaster.org">http://www.mutationtaster.org</ext-link>
</p>
</fn>
<fn id="fn02">
<label>2</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://sift.jcvi.org">http://sift.jcvi.org</ext-link>
</p>
</fn>
<fn id="fn03">
<label>3</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/">http://genetics.bwh.harvard.edu/pph2/</ext-link>
</p>
</fn>
<fn id="fn04">
<label>4</label>
<p>
<ext-link ext-link-type="uri" xlink:href="https://databases.lovd.nl/shared/variants?search_owned_by_=%3D%22Fei%20Li%22">https://databases.lovd.nl/shared/variants?search_owned_by_=%3D%22Fei%20Li%22</ext-link>
</p>
</fn>
</fn-group>
<sec sec-type="supplementary material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2018.00594/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fgene.2018.00594/full#supplementary-material</ext-link></p>
<supplementary-material content-type="local-data" id="SM1">
<label>TABLE S1</label>
<caption>
<p>Primer sequences used for validation.</p>
</caption>
<media xlink:href="Table_1.csv">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM2">
<label>TABLE S2</label>
<caption>
<p>Quality control of sequencing depth, coverage and the targeted regions covered by ≧10X reads (138X).</p>
</caption>
<media xlink:href="Table_2.csv">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Mubarak</surname><given-names>B.</given-names></name><name><surname>Abouelhoda</surname><given-names>M.</given-names></name><name><surname>Omar</surname><given-names>A.</given-names></name><name><surname>AlDhalaan</surname><given-names>H.</given-names></name><name><surname>Aldosari</surname><given-names>M.</given-names></name><name><surname>Nester</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Whole exome sequencing reveals inherited and de novo variants in autism spectrum disorder: a trio study from Saudi families.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>7</volume>:<issue>5679</issue>. <pub-id pub-id-type="doi">10.1038/s41598-017-06033-1</pub-id>
<pub-id pub-id-type="pmid">28720891</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anagnostou</surname><given-names>E.</given-names></name><name><surname>Zwaigenbaum</surname><given-names>L.</given-names></name><name><surname>Szatmari</surname><given-names>P.</given-names></name><name><surname>Fombonne</surname><given-names>E.</given-names></name><name><surname>Fernandez</surname><given-names>B. A.</given-names></name><name><surname>Woodbury-Smith</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Autism spectrum disorder: advances in evidence-based practice.</article-title>
<source/><italic>CMAJ</italic>
<volume>186</volume>
<fpage>509</fpage>–<lpage>519</lpage>. <pub-id pub-id-type="doi">10.1503/cmaj.121756</pub-id>
<pub-id pub-id-type="pmid">24418986</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baio</surname><given-names>J.</given-names></name><name><surname>Wiggins</surname><given-names>L.</given-names></name><name><surname>Christensen</surname><given-names>D. L.</given-names></name><name><surname>Maenner</surname><given-names>M. J.</given-names></name><name><surname>Daniels</surname><given-names>J.</given-names></name><name><surname>Warren</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2014.</article-title>
<source/><italic>MMWR Surveill. Summ.</italic>
<volume>67</volume>
<fpage>1</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.15585/mmwr.ss6706a1</pub-id>
<pub-id pub-id-type="pmid">29701730</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bamshad</surname><given-names>M. J.</given-names></name><name><surname>Ng</surname><given-names>S. B.</given-names></name><name><surname>Bigham</surname><given-names>A. W.</given-names></name><name><surname>Tabor</surname><given-names>H. K.</given-names></name><name><surname>Emond</surname><given-names>M. J.</given-names></name><name><surname>Nickerson</surname><given-names>D. A.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Exome sequencing as a tool for mendelian disease gene discovery.</article-title>
<source/><italic>Nat. Rev. Genet.</italic>
<volume>12</volume>
<fpage>745</fpage>–<lpage>755</lpage>. <pub-id pub-id-type="doi">10.1038/nrg3031</pub-id>
<pub-id pub-id-type="pmid">21946919</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernier</surname><given-names>R.</given-names></name><name><surname>Golzio</surname><given-names>C.</given-names></name><name><surname>Xiong</surname><given-names>B.</given-names></name><name><surname>Stessman</surname><given-names>H. A.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><name><surname>Penn</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Disruptive CHD8 mutations define a subtype of autism early in development.</article-title>
<source/><italic>Cell</italic>
<volume>158</volume>
<fpage>263</fpage>–<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.06.017</pub-id>
<pub-id pub-id-type="pmid">24998929</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betancur</surname><given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1380</volume>
<fpage>42</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2010.11.078</pub-id>
<pub-id pub-id-type="pmid">21129364</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonneau</surname><given-names>D.</given-names></name><name><surname>Longy</surname><given-names>M.</given-names></name></person-group> (<year>2000</year>). <article-title>Mutations of the human PTEN gene.</article-title>
<source/><italic>Hum. Mutat.</italic>
<volume>16</volume>
<fpage>109</fpage>–<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1002/1098-1004(200008)16:2&lt;109::AID-HUMU3&gt;3.0.CO;2-0</pub-id><pub-id pub-id-type="pmid">10923032</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colak</surname><given-names>D.</given-names></name><name><surname>Zaninovic</surname><given-names>N.</given-names></name><name><surname>Cohen</surname><given-names>M. S.</given-names></name><name><surname>Rosenwaks</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>W. Y.</given-names></name><name><surname>Gerhardt</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome.</article-title>
<source/><italic>Science</italic>
<volume>343</volume>
<fpage>1002</fpage>–<lpage>1005</lpage>. <pub-id pub-id-type="doi">10.1126/science.1245831</pub-id>
<pub-id pub-id-type="pmid">24578575</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dabell</surname><given-names>M. P.</given-names></name><name><surname>Rosenfeld</surname><given-names>J. A.</given-names></name><name><surname>Bader</surname><given-names>P.</given-names></name><name><surname>Escobar</surname><given-names>L. F.</given-names></name><name><surname>El-Khechen</surname><given-names>D.</given-names></name><name><surname>Vallee</surname><given-names>S. E.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Investigation of NRXN1 deletions: clinical and molecular characterization.</article-title>
<source/><italic>Am. J. Med. Genet. A</italic> 161A, <fpage>717</fpage>–<lpage>731</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.35780</pub-id>
<pub-id pub-id-type="pmid">23495017</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Rubeis</surname><given-names>S.</given-names></name><name><surname>He</surname><given-names>X.</given-names></name><name><surname>Goldberg</surname><given-names>A. P.</given-names></name><name><surname>Poultney</surname><given-names>C. S.</given-names></name><name><surname>Samocha</surname><given-names>K.</given-names></name><name><surname>Cicek</surname><given-names>A. E.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Synaptic, transcriptional and chromatin genes disrupted in autism.</article-title>
<source/><italic>Nature</italic>
<volume>515</volume>
<fpage>209</fpage>–<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1038/nature13772</pub-id>
<pub-id pub-id-type="pmid">25363760</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devlin</surname><given-names>B.</given-names></name><name><surname>Scherer</surname><given-names>S. W.</given-names></name></person-group> (<year>2012</year>). <article-title>Genetic architecture in autism spectrum disorder.</article-title>
<source/><italic>Curr. Opin. Genet. Dev.</italic>
<volume>22</volume>
<fpage>229</fpage>–<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1016/j.gde.2012.03.002</pub-id>
<pub-id pub-id-type="pmid">22463983</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>S.</given-names></name><name><surname>Walker</surname><given-names>M. F.</given-names></name><name><surname>Carriero</surname><given-names>N. J.</given-names></name><name><surname>DiCola</surname><given-names>M.</given-names></name><name><surname>Willsey</surname><given-names>A. J.</given-names></name><name><surname>Ye</surname><given-names>A. Y.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>De novo insertions and deletions of predominantly paternal origin are associated with autism spectrum disorder.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>9</volume>
<fpage>16</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2014.08.068</pub-id>
<pub-id pub-id-type="pmid">25284784</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez</surname><given-names>B. A.</given-names></name><name><surname>Roberts</surname><given-names>W.</given-names></name><name><surname>Chung</surname><given-names>B.</given-names></name><name><surname>Weksberg</surname><given-names>R.</given-names></name><name><surname>Meyn</surname><given-names>S.</given-names></name><name><surname>Szatmari</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder.</article-title>
<source/><italic>J. Med. Genet.</italic>
<volume>47</volume>
<fpage>195</fpage>–<lpage>203</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2009.069369</pub-id>
<pub-id pub-id-type="pmid">19755429</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gambino</surname><given-names>F.</given-names></name><name><surname>Pavlowsky</surname><given-names>A.</given-names></name><name><surname>Begle</surname><given-names>A.</given-names></name><name><surname>Dupont</surname><given-names>J. L.</given-names></name><name><surname>Bahi</surname><given-names>N.</given-names></name><name><surname>Courjaret</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>IL1-receptor accessory protein-like 1 (IL1RAPL1), a protein involved in cognitive functions, regulates N-type Ca2+-channel and neurite elongation.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>104</volume>
<fpage>9063</fpage>–<lpage>9068</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0701133104</pub-id>
<pub-id pub-id-type="pmid">17502602</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilman</surname><given-names>S. R.</given-names></name><name><surname>Iossifov</surname><given-names>I.</given-names></name><name><surname>Levy</surname><given-names>D.</given-names></name><name><surname>Ronemus</surname><given-names>M.</given-names></name><name><surname>Wigler</surname><given-names>M.</given-names></name><name><surname>Vitkup</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses.</article-title>
<source/><italic>Neuron</italic>
<volume>70</volume>
<fpage>898</fpage>–<lpage>907</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.05.021</pub-id>
<pub-id pub-id-type="pmid">21658583</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helsmoortel</surname><given-names>C.</given-names></name><name><surname>Vulto-van Silfhout</surname><given-names>A. T.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><name><surname>Vandeweyer</surname><given-names>G.</given-names></name><name><surname>Rooms</surname><given-names>L.</given-names></name><name><surname>van den Ende</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>46</volume>
<fpage>380</fpage>–<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2899</pub-id>
<pub-id pub-id-type="pmid">24531329</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herman</surname><given-names>G. E.</given-names></name><name><surname>Butter</surname><given-names>E.</given-names></name><name><surname>Enrile</surname><given-names>B.</given-names></name><name><surname>Pastore</surname><given-names>M.</given-names></name><name><surname>Prior</surname><given-names>T. W.</given-names></name><name><surname>Sommer</surname><given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title>Increasing knowledge of PTEN germline mutations: two additional patients with autism and macrocephaly.</article-title>
<source/><italic>Am. J. Med. Genet. A</italic> 143A, <fpage>589</fpage>–<lpage>593</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.31619</pub-id>
<pub-id pub-id-type="pmid">17286265</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiroi</surname><given-names>N.</given-names></name><name><surname>Takahashi</surname><given-names>T.</given-names></name><name><surname>Hishimoto</surname><given-names>A.</given-names></name><name><surname>Izumi</surname><given-names>T.</given-names></name><name><surname>Boku</surname><given-names>S.</given-names></name><name><surname>Hiramoto</surname><given-names>T.</given-names></name></person-group> (<year>2013</year>). <article-title>Copy number variation at 22q11.2: from rare variants to common mechanisms of developmental neuropsychiatric disorders.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>18</volume>
<fpage>1153</fpage>–<lpage>1165</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2013.92</pub-id>
<pub-id pub-id-type="pmid">23917946</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofvander</surname><given-names>B.</given-names></name><name><surname>Delorme</surname><given-names>R.</given-names></name><name><surname>Chaste</surname><given-names>P.</given-names></name><name><surname>Nyden</surname><given-names>A.</given-names></name><name><surname>Wentz</surname><given-names>E.</given-names></name><name><surname>Stahlberg</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Psychiatric and psychosocial problems in adults with normal-intelligence autism spectrum disorders.</article-title>
<source/><italic>BMC Psychiatry</italic>
<volume>9</volume>:<issue>35</issue>. <pub-id pub-id-type="doi">10.1186/1471-244X-9-35</pub-id>
<pub-id pub-id-type="pmid">19515234</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogart</surname><given-names>A.</given-names></name><name><surname>Wu</surname><given-names>D.</given-names></name><name><surname>LaSalle</surname><given-names>J. M.</given-names></name><name><surname>Schanen</surname><given-names>N. C.</given-names></name></person-group> (<year>2010</year>). <article-title>The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>38</volume>
<fpage>181</fpage>–<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2008.08.011</pub-id>
<pub-id pub-id-type="pmid">18840528</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iossifov</surname><given-names>I.</given-names></name><name><surname>O’Roak</surname><given-names>B. J.</given-names></name><name><surname>Sanders</surname><given-names>S. J.</given-names></name><name><surname>Ronemus</surname><given-names>M.</given-names></name><name><surname>Krumm</surname><given-names>N.</given-names></name><name><surname>Levy</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>The contribution of de novo coding mutations to autism spectrum disorder.</article-title>
<source/><italic>Nature</italic>
<volume>515</volume>
<fpage>216</fpage>–<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1038/nature13908</pub-id>
<pub-id pub-id-type="pmid">25363768</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iossifov</surname><given-names>I.</given-names></name><name><surname>Ronemus</surname><given-names>M.</given-names></name><name><surname>Levy</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Hakker</surname><given-names>I.</given-names></name><name><surname>Rosenbaum</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>De novo gene disruptions in children on the autistic spectrum.</article-title>
<source/><italic>Neuron</italic>
<volume>74</volume>
<fpage>285</fpage>–<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.04.009</pub-id>
<pub-id pub-id-type="pmid">22542183</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacquemont</surname><given-names>S.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><name><surname>Hersch</surname><given-names>M.</given-names></name><name><surname>Duyzend</surname><given-names>M. H.</given-names></name><name><surname>Krumm</surname><given-names>N.</given-names></name><name><surname>Bergmann</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>A higher mutational burden in females supports a ”female protective model” in neurodevelopmental disorders.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>94</volume>
<fpage>415</fpage>–<lpage>425</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2014.02.001</pub-id>
<pub-id pub-id-type="pmid">24581740</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamain</surname><given-names>S.</given-names></name><name><surname>Quach</surname><given-names>H.</given-names></name><name><surname>Betancur</surname><given-names>C.</given-names></name><name><surname>Rastam</surname><given-names>M.</given-names></name><name><surname>Colineaux</surname><given-names>C.</given-names></name><name><surname>Gillberg</surname><given-names>I. C.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>34</volume>
<fpage>27</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1038/ng1136</pub-id>
<pub-id pub-id-type="pmid">12669065</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H. G.</given-names></name><name><surname>Kishikawa</surname><given-names>S.</given-names></name><name><surname>Higgins</surname><given-names>A. W.</given-names></name><name><surname>Seong</surname><given-names>I. S.</given-names></name><name><surname>Donovan</surname><given-names>D. J.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Disruption of neurexin 1 associated with autism spectrum disorder.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>82</volume>
<fpage>199</fpage>–<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2007.09.011</pub-id>
<pub-id pub-id-type="pmid">18179900</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohane</surname><given-names>I. S.</given-names></name><name><surname>McMurry</surname><given-names>A.</given-names></name><name><surname>Weber</surname><given-names>G.</given-names></name><name><surname>MacFadden</surname><given-names>D.</given-names></name><name><surname>Rappaport</surname><given-names>L.</given-names></name><name><surname>Kunkel</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>The co-morbidity burden of children and young adults with autism spectrum disorders.</article-title>
<source/><italic>PLoS One</italic>
<volume>7</volume>:<issue>e33224</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0033224</pub-id>
<pub-id pub-id-type="pmid">22511918</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>D.</given-names></name><name><surname>Ronemus</surname><given-names>M.</given-names></name><name><surname>Yamrom</surname><given-names>B.</given-names></name><name><surname>Lee</surname><given-names>Y. H.</given-names></name><name><surname>Leotta</surname><given-names>A.</given-names></name><name><surname>Kendall</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Rare de novo and transmitted copy-number variation in autistic spectrum disorders.</article-title>
<source/><italic>Neuron</italic>
<volume>70</volume>
<fpage>886</fpage>–<lpage>897</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.05.015</pub-id>
<pub-id pub-id-type="pmid">21658582</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>C. R.</given-names></name><name><surname>Noor</surname><given-names>A.</given-names></name><name><surname>Vincent</surname><given-names>J. B.</given-names></name><name><surname>Lionel</surname><given-names>A. C.</given-names></name><name><surname>Feuk</surname><given-names>L.</given-names></name><name><surname>Skaug</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Structural variation of chromosomes in autism spectrum disorder.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>82</volume>
<fpage>477</fpage>–<lpage>488</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2007.12.009</pub-id>
<pub-id pub-id-type="pmid">18252227</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattila</surname><given-names>M. L.</given-names></name><name><surname>Hurtig</surname><given-names>T.</given-names></name><name><surname>Haapsamo</surname><given-names>H.</given-names></name><name><surname>Jussila</surname><given-names>K.</given-names></name><name><surname>Kuusikko-Gauffin</surname><given-names>S.</given-names></name><name><surname>Kielinen</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Comorbid psychiatric disorders associated with Asperger syndrome/high-functioning autism: a community- and clinic-based study.</article-title>
<source/><italic>J. Autism Dev. Disord.</italic>
<volume>40</volume>
<fpage>1080</fpage>–<lpage>1093</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-010-0958-2</pub-id>
<pub-id pub-id-type="pmid">20177765</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miles</surname><given-names>J. H.</given-names></name><name><surname>Takahashi</surname><given-names>T. N.</given-names></name><name><surname>Bagby</surname><given-names>S.</given-names></name><name><surname>Sahota</surname><given-names>P. K.</given-names></name><name><surname>Vaslow</surname><given-names>D. F.</given-names></name><name><surname>Wang</surname><given-names>C. H.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Essential versus complex autism: definition of fundamental prognostic subtypes.</article-title>
<source/><italic>Am. J. Med. Genet. A</italic>
<volume>135</volume>
<fpage>171</fpage>–<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.30590</pub-id>
<pub-id pub-id-type="pmid">15887228</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moessner</surname><given-names>R.</given-names></name><name><surname>Marshall</surname><given-names>C. R.</given-names></name><name><surname>Sutcliffe</surname><given-names>J. S.</given-names></name><name><surname>Skaug</surname><given-names>J.</given-names></name><name><surname>Pinto</surname><given-names>D.</given-names></name><name><surname>Vincent</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Contribution of SHANK3 mutations to autism spectrum disorder.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>81</volume>
<fpage>1289</fpage>–<lpage>1297</lpage>. <pub-id pub-id-type="doi">10.1086/522590</pub-id>
<pub-id pub-id-type="pmid">17999366</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neale</surname><given-names>B. M.</given-names></name><name><surname>Kou</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Ma’ayan</surname><given-names>A.</given-names></name><name><surname>Samocha</surname><given-names>K. E.</given-names></name><name><surname>Sabo</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Patterns and rates of exonic de novo mutations in autism spectrum disorders.</article-title>
<source/><italic>Nature</italic>
<volume>485</volume>
<fpage>242</fpage>–<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1038/nature11011</pub-id>
<pub-id pub-id-type="pmid">22495311</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishiyama</surname><given-names>M.</given-names></name><name><surname>Oshikawa</surname><given-names>K.</given-names></name><name><surname>Tsukada</surname><given-names>Y.</given-names></name><name><surname>Nakagawa</surname><given-names>T.</given-names></name><name><surname>Iemura</surname><given-names>S.</given-names></name><name><surname>Natsume</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>CHD8 suppresses p53-mediated apoptosis through histone H1 recruitment during early embryogenesis.</article-title>
<source/><italic>Nat. Cell Biol.</italic>
<volume>11</volume>
<fpage>172</fpage>–<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1038/ncb1831</pub-id>
<pub-id pub-id-type="pmid">19151705</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noor</surname><given-names>A.</given-names></name><name><surname>Whibley</surname><given-names>A.</given-names></name><name><surname>Marshall</surname><given-names>C. R.</given-names></name><name><surname>Gianakopoulos</surname><given-names>P. J.</given-names></name><name><surname>Piton</surname><given-names>A.</given-names></name><name><surname>Carson</surname><given-names>A. R.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability.</article-title>
<source/><italic>Sci. Transl. Med.</italic>
<volume>2</volume>:<issue>49ra68</issue>. <pub-id pub-id-type="doi">10.1126/scitranslmed.3001267</pub-id>
<pub-id pub-id-type="pmid">20844286</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Roak</surname><given-names>B. J.</given-names></name><name><surname>Deriziotis</surname><given-names>P.</given-names></name><name><surname>Lee</surname><given-names>C.</given-names></name><name><surname>Vives</surname><given-names>L.</given-names></name><name><surname>Schwartz</surname><given-names>J. J.</given-names></name><name><surname>Girirajan</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>43</volume>
<fpage>585</fpage>–<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1038/ng.835</pub-id>
<pub-id pub-id-type="pmid">21572417</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Roak</surname><given-names>B. J.</given-names></name><name><surname>Stessman</surname><given-names>H. A.</given-names></name><name><surname>Boyle</surname><given-names>E. A.</given-names></name><name><surname>Witherspoon</surname><given-names>K. T.</given-names></name><name><surname>Martin</surname><given-names>B.</given-names></name><name><surname>Lee</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Recurrent de novo mutations implicate novel genes underlying simplex autism risk.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>5</volume>:<issue>5595</issue>. <pub-id pub-id-type="doi">10.1038/ncomms6595</pub-id>
<pub-id pub-id-type="pmid">25418537</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Roak</surname><given-names>B. J.</given-names></name><name><surname>Vives</surname><given-names>L.</given-names></name><name><surname>Girirajan</surname><given-names>S.</given-names></name><name><surname>Karakoc</surname><given-names>E.</given-names></name><name><surname>Krumm</surname><given-names>N.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations.</article-title>
<source/><italic>Nature</italic>
<volume>485</volume>
<fpage>246</fpage>–<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1038/nature10989</pub-id>
<pub-id pub-id-type="pmid">22495309</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piton</surname><given-names>A.</given-names></name><name><surname>Michaud</surname><given-names>J. L.</given-names></name><name><surname>Peng</surname><given-names>H.</given-names></name><name><surname>Aradhya</surname><given-names>S.</given-names></name><name><surname>Gauthier</surname><given-names>J.</given-names></name><name><surname>Mottron</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Mutations in the calcium-related gene IL1RAPL1 are associated with autism.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>17</volume>
<fpage>3965</fpage>–<lpage>3974</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddn300</pub-id>
<pub-id pub-id-type="pmid">18801879</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronan</surname><given-names>J. L.</given-names></name><name><surname>Wu</surname><given-names>W.</given-names></name><name><surname>Crabtree</surname><given-names>G. R.</given-names></name></person-group> (<year>2013</year>). <article-title>From neural development to cognition: unexpected roles for chromatin.</article-title>
<source/><italic>Nat. Rev. Genet.</italic>
<volume>14</volume>
<fpage>347</fpage>–<lpage>359</lpage>. <pub-id pub-id-type="doi">10.1038/nrg3413</pub-id>
<pub-id pub-id-type="pmid">23568486</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>S. J.</given-names></name><name><surname>Ercan-Sencicek</surname><given-names>A. G.</given-names></name><name><surname>Hus</surname><given-names>V.</given-names></name><name><surname>Luo</surname><given-names>R.</given-names></name><name><surname>Murtha</surname><given-names>M. T.</given-names></name><name><surname>Moreno-De-Luca</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism.</article-title>
<source/><italic>Neuron</italic>
<volume>70</volume>
<fpage>863</fpage>–<lpage>885</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.05.002</pub-id>
<pub-id pub-id-type="pmid">21658581</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>S. J.</given-names></name><name><surname>Murtha</surname><given-names>M. T.</given-names></name><name><surname>Gupta</surname><given-names>A. R.</given-names></name><name><surname>Murdoch</surname><given-names>J. D.</given-names></name><name><surname>Raubeson</surname><given-names>M. J.</given-names></name><name><surname>Willsey</surname><given-names>A. J.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>De novo mutations revealed by whole-exome sequencing are strongly associated with autism.</article-title>
<source/><italic>Nature</italic>
<volume>485</volume>
<fpage>237</fpage>–<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1038/nature10945</pub-id>
<pub-id pub-id-type="pmid">22495306</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>D.</given-names></name><name><surname>Lionel</surname><given-names>A. C.</given-names></name><name><surname>Leblond</surname><given-names>C. S.</given-names></name><name><surname>Prasad</surname><given-names>A.</given-names></name><name><surname>Pinto</surname><given-names>D.</given-names></name><name><surname>Walker</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>SHANK1 deletions in males with autism spectrum disorder.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>90</volume>
<fpage>879</fpage>–<lpage>887</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.03.017</pub-id>
<pub-id pub-id-type="pmid">22503632</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Dies</surname><given-names>K. A.</given-names></name><name><surname>Holm</surname><given-names>I. A.</given-names></name><name><surname>Bridgemohan</surname><given-names>C.</given-names></name><name><surname>Sobeih</surname><given-names>M. M.</given-names></name><name><surname>Caronna</surname><given-names>E. B.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Clinical genetic testing for patients with autism spectrum disorders.</article-title>
<source/><italic>Pediatrics</italic>
<volume>125</volume>
<fpage>e727</fpage>–<lpage>e735</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2009-1684</pub-id>
<pub-id pub-id-type="pmid">20231187</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>State</surname><given-names>M. W.</given-names></name><name><surname>Levitt</surname><given-names>P.</given-names></name></person-group> (<year>2011</year>). <article-title>The conundrums of understanding genetic risks for autism spectrum disorders.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>14</volume>
<fpage>1499</fpage>–<lpage>1506</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2924</pub-id>
<pub-id pub-id-type="pmid">22037497</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefanatos</surname><given-names>G. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Regression in autistic spectrum disorders.</article-title>
<source/><italic>Neuropsychol. Rev.</italic>
<volume>18</volume>
<fpage>305</fpage>–<lpage>319</lpage>. <pub-id pub-id-type="doi">10.1007/s11065-008-9073-y</pub-id>
<pub-id pub-id-type="pmid">18956241</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stessman</surname><given-names>H. A. F.</given-names></name><name><surname>Willemsen</surname><given-names>M. H.</given-names></name><name><surname>Fenckova</surname><given-names>M.</given-names></name><name><surname>Penn</surname><given-names>O.</given-names></name><name><surname>Hoischen</surname><given-names>A.</given-names></name><name><surname>Xiong</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Disruption of POGZ is associated with intellectual disability and autism spectrum disorders.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>98</volume>
<fpage>541</fpage>–<lpage>552</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2016.02.004</pub-id>
<pub-id pub-id-type="pmid">26942287</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tammimies</surname><given-names>K.</given-names></name><name><surname>Marshall</surname><given-names>C. R.</given-names></name><name><surname>Walker</surname><given-names>S.</given-names></name><name><surname>Kaur</surname><given-names>G.</given-names></name><name><surname>Thiruvahindrapuram</surname><given-names>B.</given-names></name><name><surname>Lionel</surname><given-names>A. C.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Molecular diagnostic yield of chromosomal microarray analysis and whole-exome sequencing in children with autism spectrum disorder.</article-title>
<source/><italic>JAMA</italic>
<volume>314</volume>
<fpage>895</fpage>–<lpage>903</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2015.10078</pub-id>
<pub-id pub-id-type="pmid">26325558</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>T. Y.</given-names></name><name><surname>Dillon</surname><given-names>O. J.</given-names></name><name><surname>Stark</surname><given-names>Z.</given-names></name><name><surname>Schofield</surname><given-names>D.</given-names></name><name><surname>Alam</surname><given-names>K.</given-names></name><name><surname>Shrestha</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Diagnostic impact and cost-effectiveness of whole-exome sequencing for ambulant children with suspected monogenic conditions.</article-title>
<source/><italic>JAMA Pediatr.</italic>
<volume>171</volume>
<fpage>855</fpage>–<lpage>862</lpage>. <pub-id pub-id-type="doi">10.1001/jamapediatrics.2017.1755</pub-id>
<pub-id pub-id-type="pmid">28759686</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal">The Lancet (<year>2010</year>). <article-title>DSM-5: diagnosis of mental disorders.</article-title>
<source/><italic>Lancet</italic>
<volume>376</volume>:<issue>390</issue>.</mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>L. A.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Korn</surname><given-names>J. M.</given-names></name><name><surname>Arking</surname><given-names>D. E.</given-names></name><name><surname>Miller</surname><given-names>D. T.</given-names></name><name><surname>Fossdal</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Association between microdeletion and microduplication at 16p11.2 and autism.</article-title>
<source/><italic>N. Engl. J. Med.</italic>
<volume>358</volume>
<fpage>667</fpage>–<lpage>675</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa075974</pub-id>
<pub-id pub-id-type="pmid">18184952</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>F.</given-names></name><name><surname>Danko</surname><given-names>T.</given-names></name><name><surname>Botelho</surname><given-names>S. C.</given-names></name><name><surname>Patzke</surname><given-names>C.</given-names></name><name><surname>Pak</surname><given-names>C.</given-names></name><name><surname>Wernig</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons.</article-title>
<source/><italic>Science</italic>
<volume>352</volume>:<issue>aaf2669</issue>. <pub-id pub-id-type="doi">10.1126/science.aaf2669</pub-id>
<pub-id pub-id-type="pmid">26966193</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>T. W.</given-names></name><name><surname>Chahrour</surname><given-names>M. H.</given-names></name><name><surname>Coulter</surname><given-names>M. E.</given-names></name><name><surname>Jiralerspong</surname><given-names>S.</given-names></name><name><surname>Okamura-Ikeda</surname><given-names>K.</given-names></name><name><surname>Ataman</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Using whole-exome sequencing to identify inherited causes of autism.</article-title>
<source/><italic>Neuron</italic>
<volume>77</volume>
<fpage>259</fpage>–<lpage>273</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.11.002</pub-id>
<pub-id pub-id-type="pmid">23352163</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>